CVS Health Corporation$100.05HD · NYSE
| FY2027 | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $164.68B | $159.51B | $152.67B | $157.40B | $151.16B | $132.11B | $110.22B | $108.20B |
| Cost of Revenue | $109.82B | $106.21B | $101.71B | $104.63B | $100.33B | $87.26B | $72.65B | $71.04B |
| Gross Profit | $54.87B | $53.31B | $50.96B | $52.78B | $50.83B | $44.85B | $37.57B | $37.16B |
| Selling, General & Administrative | $30.70B | $28.75B | $26.60B | $26.28B | $25.41B | $24.45B | $19.74B | $19.51B |
| Operating Expenses | $33.98B | $31.78B | $29.27B | $28.74B | $27.79B | $26.57B | $21.73B | $21.63B |
| Operating Income | $20.89B | $21.53B | $21.69B | $24.04B | $23.04B | $18.28B | $15.84B | $15.53B |
| Interest Expense | — | — | $1.94B | $1.62B | $1.35B | $1.35B | $1.20B | $1.05B |
| Other Income / (Expense) | -$2.29B | -$2.12B | -$1.76B | -$1.56B | -$1.30B | -$1.30B | -$1.13B | -$974.00M |
| Income Before Taxes | $18.60B | $19.41B | $19.92B | $22.48B | $21.74B | $16.98B | $14.71B | $14.56B |
| Provision for Income Taxes | $4.45B | $4.60B | $4.78B | $5.37B | $5.30B | $4.11B | $3.47B | $3.44B |
| Net Income | $14.16B | $14.81B | $15.14B | $17.11B | $16.43B | $12.87B | $11.24B | $11.12B |
| Basic EPS | $14.26 | $14.96 | $15.16 | $16.74 | $15.59 | $11.98 | $10.29 | $9.78 |
| Diluted EPS | $14.23 | $14.91 | $15.11 | $16.69 | $15.53 | $11.94 | $10.25 | $9.73 |
| Basic Shares Outstanding | 993.00M | 990.00M | 999.00M | 1.02B | 1.05B | 1.07B | 1.09B | 1.14B |
| Diluted Shares Outstanding | 995.00M | 993.00M | 1.00B | 1.02B | 1.06B | 1.08B | 1.10B | 1.14B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $15.01 | $14.85 | $15.16 | 15 | ↑0 ↓0 |
| Jan 2028 | $16.21 | $15.70 | $16.52 | 16 | ↑0 ↓0 |
| Jan 2029 | $17.64 | $16.87 | $18.02 | 6 | ↑0 ↓0 |
| Jan 2030 | $18.63 | $18.02 | $19.24 | 2 | ↑0 ↓0 |
